Clinical Trial Highlights - Infusion Therapies

被引：9

作者：

Prakash, Neha ^{[1
]}

McFarthing, Kevin ^{[2
]}

Simuni, Tanya ^{[3
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Parkinsons Dis & Movement Disorders Ctr, Farmington, CT USA

[2] Innovat Fixer Ltd, Oxford, England

[3] Northwestern Univ, Feinberg Sch Med, Parkinsons Dis & Movement Disorders Ctr, Chicago, IL 60611 USA

来源：

JOURNAL OF PARKINSONS DISEASE | 2020年 / 10卷 / 01期

关键词：

SUBCUTANEOUS APOMORPHINE INFUSION; PARKINSONS-DISEASE; FORMULATION; MOTOR;

D O I：

10.3233/JPD-199005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：5 / 17

页数：13

共 17 条

[1]

Caraco Y, 2013, MOVEMENT DISORD, V28, pS162

[2] Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features [J].

Chaudhuri, K. Ray ;

Poewe, Werner ;

Brooks, David .

MOVEMENT DISORDERS, 2018, 33 (06) :909-919

[3] Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease [J].

Duprez, Joan ;

Houvenaghel, Jean-Francois ;

Drapier, Sophie ;

Auffret, Manon ;

Drapier, Dominique ;

Robert, Gabriel ;

Verin, Marc ;

Sauleau, Paul .

JOURNAL OF NEUROLOGY, 2018, 265 (03) :471-477

[4] Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life [J].

Houvenaghel, Jean-Francois ;

Drapier, Sophie ;

Duprez, Joan ;

Robert, Gabriel Hadrien ;

Riou, Audrey ;

Drapier, Dominique ;

Sauleau, Paul ;

Verin, Marc .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 395 :113-118

[5] Apomorphine - pharmacological properties and clinical trials in Parkinson's disease [J].

Jenner, Peter ;

Katzenschlager, Regina .

PARKINSONISM & RELATED DISORDERS, 2016, 33 :S13-S21

[6] Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial [J].

Katzenschlager, Regina ;

Poewe, Werner ;

Rascol, Olivier ;

Trenkwalder, Claudia ;

Deuschl, Gunther ;

Chaudhuri, K. Ray ;

Henriksen, Tove ;

van Laar, Teus ;

Spivey, Kevin ;

Vel, Senthil ;

Staines, Harry ;

Lees, Andrew .

LANCET NEUROLOGY, 2018, 17 (09) :749-759

[7] Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study [J].

Lopiano, Leonardo ;

Modugno, Nicola ;

Marano, Pietro ;

Sensi, Mariachiara ;

Meco, Giuseppe ;

Solla, Paolo ;

Gusmaroli, Graziano ;

Tamma, Filippo ;

Mancini, Francesca ;

Quatrale, Rocco ;

Zangaglia, Roberta ;

Bentivoglio, Annarita ;

Eleopra, Roberto ;

Gualberti, Giuliana ;

Melzi, Gabriella ;

Antonini, Angelo .

JOURNAL OF NEUROLOGY, 2019, 266 (09) :2164-2176

[8] CLINICAL TRIAL HIGHLIGHTS 1. GENE THERAPY FOR PARKINSON'S 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL 3. CLINICAL TRIALS RESOURCES [J].

McFarthing, Kevin ;

Prakash, Neha ;

Simuni, Tanya .

JOURNAL OF PARKINSONS DISEASE, 2019, 9 (02) :251-264

[9] Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations [J].

Modi, Nishit B. ;

Mittur, Aravind ;

Dinh, Phillip ;

Rubens, Robert ;

Gupta, Suneel .

CLINICAL NEUROPHARMACOLOGY, 2019, 42 (05) :149-156

[10] Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules [J].

Modi, Nishit B. ;

Mittur, Aravind ;

Rubens, Robert ;

Khanna, Sarita ;

Gupta, Suneel .

CLINICAL NEUROPHARMACOLOGY, 2019, 42 (01) :4-8

← 1 2 →